BOTHELL, Wash.--(BUSINESS WIRE)--Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and chief executive officer, will present during a session at the BioJapan 2009 World Business Forum. The English language session, entitled “Successful Alliances Between Emerging Companies and Big Pharma,” is scheduled to be held at 3:00 p.m. JST on Thursday, October 8, 2009 at the Pacifico Yokohama in Yokohama, Japan.
